Adopted opinions and previous consultations on applications for authorisation

Adopted opinions and previous consultations on applications for authorisation

Adopted opinions and previous consultations on applications for authorisation

This page provides further information on the applications for authorisation or review reports, which have undergone consultation. The applications for authorisation are in the opinion development phase until the final opinions of the Committees for Risk Assessment and Socio-economic Analysis have been adopted and sent to the European Commission. Its decision-making process can be followed through the comitology register, where further information is published about the REACH Committee's past and upcoming meetings.

On 1 February 2020, the United Kingdom (UK) withdrew from the EU. The transition period provided by the withdrawal agreement ended on 31 December 2020. As of 1 January 2021, an application for an authorisation submitted by a person established in the UK (except Northern Ireland) is no longer valid in the EU, unless that application has been transferred to a legal entity established in the EU or Northern Ireland before the end of the transition period. Therefore, authorisation applications and decisions in so far as these concern persons established in the UK (except Northern Ireland) are no longer considered valid. 

 

There are currently no ongoing consultations.
 
0155-01 Initial 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated - - Kedrion S.p.A Use of 4-tert-OPnEO as Triton X-100 as detergent for virus inactivation in the manufacturing process of the human plasma-derived medicinal products Plasmagrade/Plasmasafe and Resusix, as well as Plasminogen (pre-commercialization name) and any subsequent commercialization brand Commission decided Details
0038-01 Initial Sodium dichromate 234-190-3
7789-12-0
10588-01-9
Kemira Chemicals Oy Use of Sodium dichromate as an additive for suppressing parasitic reactions and oxygen evolution, pH buffering and cathode corrosion protection in the electrolytic manufacture of sodium chlorate with or without subsequent production of chlorine dioxide or sodium chlorite Commission decided Details
0231-01 Initial Chromium trioxide 215-607-8 1333-82-0 Kesseboehmer Beschlagsysteme GmbH&Co.KG Use of chromium trioxide for decorative/functional application in the furniture, sanitary and automotive sector. Opinions adopted Details
0132-02 Initial Chromium trioxide 215-607-8 1333-82-0 KEUCO GmbH & Co KG Etching of plastics with chromium trioxide as pre-treatment step for electroplating processes Commission decided Details
0132-01 Initial Chromium trioxide 215-607-8 1333-82-0 KEUCO GmbH & Co KG Electroplating of different types of substrates using chromium trioxide to achieve functional surfaces with high durability and a bright or matt silvery appearance for sanitary applications Commission decided Details
0294-02 Initial Chromium trioxide 215-607-8 1333-82-0 Kludi GmbH & Co. KG Pre-treatment (“etching”) of plastic substrates using chromium trioxide in electroplating processes for sanitary applications Opinions adopted Details
0294-01 Initial Chromium trioxide 215-607-8 1333-82-0 Kludi GmbH & Co. KG; Kludi-Armaturen Austria Ges.m.b.H. Functional chrome plating with decorative character of metal and plastic substrates for sanitary applications Opinions adopted Details
0150-02 Initial Anthracene oil 292-602-7 90640-80-5 Koppers Denmark ApS Use of AO for manufacture of formulations for various industrial uses Commission decided Details
0150-01 Initial Pitch, coal tar, high temp. 266-028-2 65996-93-2 Koppers Denmark ApS Use of CTPht for manufacture of formulations for various industrial uses Commission decided Details
0283-01 Initial Chromium trioxide 215-607-8 1333-82-0 KYB SUSPENSIONS EUROPE, S.A.U.; KYB Manufacturing Czech s.r.o. Functional chrome plating of piston rods for shock absorbers for automotive applications Opinions adopted Details